Navigation Links
ATP synthase


An ATP synthase (EC 3.6.3.14) is a general term for an enzyme that can synthesize adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phosphate by utilizing some form of energy. The overall reaction sequence is:

ADP + Pi → ATP
ATP synthase in E. coli

These enzymes are of crucial importance in almost all organisms, because ATP is the common "energy currency" of cells.

In mitochondria, the FOF1 ATP synthase has a long history of scientific study. The F1 portion of the ATP synthase is above the membrane, the FO portion is within the membrane. It's easy to visualize the FOF1 particle as resembling the fruiting body of a common mushroom, with the head being the F1 particle, the stalk being the gamma subunit of F1, and the base and "roots" being the FO particle embedded in the membrane. The F1 particle was first isolated by Ephraim Racker in 1961.

The F1 particle is large and can be seen in the transmission electron microscope by negative staining (1962, Fernandez-Moran et al., Journal of Molecular Biology, Vol 22, p 63). These are particles of 9 nm diameter that pepper the inner mitochondrial membrane. They were originally called elementary particles and were thought to contain the entire respiratory apparatus of the mitochondrion, but through a long series of experiments, Ephraim Racker and his colleagues were able to show that this particle is correlated with ATPase activity in uncoupled mitochondria and with the ATPase activity in submitochondrial particles created by exposing mitochondria to ultrasound. This ATPase activity was further associated with the creation of ATP by yet another long series of experiments in many laboratories.

Contents

Binding change mechanism

In the 1960s through the 1970s, Paul Boyer developed his binding change, or flip-flop, mechanism, which postulated that ATP synthesis is coupled with a conformational change in the ATP synthase generated by rotation of the gamma subunit. John E. Walker crystallized the ATP synthase and was able to determine that Boyer's conformational model was essentially correct. In the crystal structure, the F1 particle can be seen to be composed of a cylinder of 6 subunits, alternating alpha and beta subunits, that form a ring around an asymmetrical gamma subunit. Facilitated diffusion of protons causes the FO particle to rotate, rotating the gamma subunit of F1, while the major F1 subunits are fixed in place. This rotation forces a conformational change in the F1 particle, eventually leading to the synthesis of ATP. For elucidating this Boyer and Walker shared in the 1997 Nobel Prize in Chemistry.

Physiological role

The F1FO ATP synthase is a reversible enzyme. Large enough quantities of ATP cause it to create a transmembrane proton gradient, this is used by fermenting bacteria which do not have an electron transport chain, and hydrolyze ATP to make a proton gradient, which they use for flagella and transport of nutrients into the cell.

In respiring bacteria under physiological conditions, ATP synthase generally runs in the opposite direction, creating ATP while using the protonmotive force created by the electron transport chain as a source of energy. The overall process of creating energy in this fashion is termed oxidative phosphorylation. Same process takes place in mitochondria, were ATP synthase is located in the inner mitochondrial membrane (so that F1-part sticks into mitochondrial matrix, were ATP synthesis takes place).

Plant ATP synthase

In plants ATP synthase is also present in chloroplasts (CFOF1-ATP synthase). The enzyme is integrated into thylakoid membrane; the CF1-part sticks into stroma, were dark reactions of photosynthesis (Calvin cycle) and ATP synthesis take place. The overall structure and the catalytic mechanism of the chloroplast ATP synthase are almost the same as those of the mitochondrial enzyme. However, in chloroplasts the protonmotive force is generated not by respiratory electron transport chain, but by primary photosynthetic proteins - photosystems I and II and cytochrome b6f.

E. coli ATP synthase

E. coli ATP synthase is the simplest known form of ATP synthase, with 8 different subunit types.

Yeast ATP synthase

Yeast ATP synthase is the most complex known and is made of 20 different types of subunits.

See also

External links


'"/>


See more about: ATP synthase

TAG: ATP synthase
(Date:11/24/2009)...is release is available in Spanish . , The ...er levels of inflammatory substances in the blood,...as shown by a research project of the University o... scientist at the School of Pharmacy. , The proj...dy in relation to the control of body weight and i...
(Date:11/23/2009)... Cambridge, Mass. November 23, 2009 Applied math...n lily ( Hosta lancifolia ), a characteristic long...y packed ripples along the edges. The simple cause...sulting from bending during differential growthwas...retching foam ribbons. , Haiyi Liang, a postdoct...
(Date:11/23/2009)...INE, Calif. -- More than 160 participants gathered...es Keck FUTURES INITIATIVE conference. This year,s...ntists, engineers, and medical researchers to expl... surrounding the emerging field of synthetic biolo...biology at Princeton University and this year,s co...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2EHE International Supports The Michael J Fox Foundation for Parkinsons Research 53849 1EHE International Supports The Michael J Fox Foundation for Parkinsons Research 53849 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 1Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 3Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 4Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 5Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 6Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 1Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference 53844 2
...ALR) recently announced it will award nearly $7 mi... very proud to announce, during National Minority ... the ALR has funded more than 100 research project..., since our founding in 1999, says ALR President B...he ALRs website, www.lupusresearch.org . , Twen...
...icine have identified, characterized and cloned ov...stem cells may be the source of ovarian cancers re...hese results bring us closer to more effective and... one of the most lethal forms of cancer, said Gil ...f Obstetrics, Gynecology & Reproductive Sciences a...
...killed between 30 and 50 million people. In the in...cute respiratory distress syndrome (ARDS). This fa...ring which the lung becomes severely damaged. ARDS...ections, but also by chemical agents. These could ...en aspirated. Once ARDS has developed, survival ra...
Other Biology News:The Alliance for Lupus Research announces 2008 grantees 2Ovarian cancer stem cells identified, characterized 2New strategies against bird flu 2
Other biology definitionOther TagsGilafoetuslabelsOTCOTCgraveICIICIICIICIICIICIICIICIICI